The World Health Organization (WHO) has officially declared the rapidly expanding Ebola outbreak in the Democratic Republic of Congo (DRC) and Uganda a Public Health Emergency of International Concern (PHEIC). This decision, announced over the weekend by WHO Director-General Dr. Tedros Adhanom Ghebreyesus, follows the explosive spread of the rare Bundibugyo ebolavirus strain, an development that public health experts in Nigeria warn poses an immediate threat to the entire West African sub-region if border protocols falter.
The Anatomy of a Stealth Outbreak
According to official data released by global health monitors, the crisis began as a mysterious, high-mortality illness in the Mongbwalu health zone of the DRC’s Ituri Province in late April. The scale of the threat was dangerously masked because initial diagnostic tests—which are specifically calibrated to detect the common Zaire ebolavirus strain—returned negative results.
By the time the Institut National de Recherche Biomédicale (INRB) in Kinshasa deployed specialized genomic fingerprinting tools, the virus had already established a firm foothold. As of today, the epidemic has left nearly 90 dead, with over 330 suspected cases across multiple provinces.
More alarming for international aviation hubs like Lagos and Abuja is that the virus has bypassed remote forests entirely. Confirmed cases have already been detected in major urban centers, including the DRC’s capital city of Kinshasa, and across the international border into Uganda’s capital, Kampala. The recent detection of a positive case in Goma—a highly volatile city in North Kivu Province currently under the control of the M23 rebel movement—has further amplified international anxieties.
The Nightmare Scenario: No Approved Vaccine
For the Nigerian center for Disease Control (NCDC), the true point of concern is the biology of the pathogen itself. Unlike previous Ebola outbreaks where health workers deployed the highly effective Ervebo vaccine to create immune rings around infections, there is currently no approved vaccine or specific therapeutic drug for the Bundibugyo strain.
“We are dealing with a variant that exhibits a case-fatality rate between 25% and 50%, and our pharmaceutical toolkit is entirely empty,” a senior director at the NCDC stated on condition of anonymity. “The only defense we have right now is aggressive, old-school epidemiology: rapid isolation, immaculate contact tracing, and absolute border vigilance.”
Nigeria Activates Airport Screenings
In immediate response to the WHO’s declaration, port health officials at the Murtala Muhammed International Airport in Lagos and Nnamdi Azikiwe International Airport in Abuja have reinstituted mandatory temperature checks and health declaration forms for all incoming passengers from Central and East Africa.
While the WHO has explicitly advised against international trade and travel restrictions—stating that such bans often drive travelers toward unmonitored, informal routes—the NCDC is urging extreme caution. Nigerian airlines operating regional routes have been instructed to report any passengers exhibiting non-specific early symptoms, such as acute fever, intense fatigue, or muscle pain, which can easily be misdiagnosed as severe malaria or typhoid.
With at least four healthcare workers already dead in the DRC due to initial gaps in Infection Prevention and Control (IPC) measures, Nigeria’s medical associations are calling on the Federal Government to immediately audit the personal protective equipment (PPE) stock in all federal tertiary hospitals. The memory of the 2014 Patrick Sawyer case remains a potent reminder of how quickly a single air traveler can bring a global health emergency to the streets of Lagos.
